BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32691542)

  • 1. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
    Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
    AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
    Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
    Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
    Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of magnetic resonance tumour regression grade in the prediction of regression and survival of rectal adenocarcinoma after long-course chemoradiotherapy: a cohort study.
    Chen HLR; Seow-En I; Chok AY; Ngo NT; Cheng TL; Tan KE
    Ann Med Surg (Lond); 2023 Apr; 85(4):842-848. PubMed ID: 37113901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI tumour regression grade in locally recurrent rectal cancer.
    Voogt ELK; Nordkamp S; van Zoggel DMGI; Daniëls-Gooszen AW; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Cnossen JS; van Lijnschoten G; Burger JWA; Rutten HJT; Nederend J
    BJS Open; 2022 May; 6(3):. PubMed ID: 35552373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 8. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
    Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
    Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.
    Pikūnienė I; Strakšytė V; Basevičius A; Žilinskas J; Ambrazienė R; Jančiauskienė R; Saladžinskas Ž
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138297
    [No Abstract]   [Full Text] [Related]  

  • 10. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
    Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
    Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
    Yoo GS; Park HC; Yu JI; Choi DH; Cho WK; Park YS; Park JO; Lim HY; Kang WK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Song KD; Kim SH; Ha SY
    Cancer Res Treat; 2020 Apr; 52(2):446-454. PubMed ID: 31588705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: multi-readers' diagnostic performance.
    Bae JS; Kim SH; Hur BY; Chang W; Park J; Park HE; Kim JH; Kang HJ; Yu MH; Han JK
    Eur Radiol; 2019 Aug; 29(8):4379-4388. PubMed ID: 30617483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
    Lee HJ; Chung WS; An JH; Kim JH
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal Signet Ring Cell Carcinoma: Post-Chemoradiotherapy Evaluation by MRI and Corresponding to Pathology.
    Zhou Y; Li Q; Mao Y
    Front Surg; 2022; 9():841645. PubMed ID: 35310426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
    Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice.
    Kim HY; Cho SH; Jang JK; Kim B; Lee CM; Lim JS; Moon SK; Oh SN; Seo N; Park SH
    Korean J Radiol; 2024 Apr; 25(4):351-362. PubMed ID: 38528693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MRI response evaluation methods in rectal cancer: a multicentre and multireader validation study.
    El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
    Eur Radiol; 2023 Jun; 33(6):4367-4377. PubMed ID: 36576549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
    Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
    Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.